Risedronate Sodium (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Risedronate Sodium drug offered from Teva Pharmaceuticals USA Inc. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
| NON-PROPRIETARY NAME: | Risedronate Sodium |
| SUBSTANCE NAME: | RISEDRONATE SODIUM MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-05-18 |
| END MARKETING DATE: | 0000-00-00 |
Risedronate Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Risedronate Sodium from Teva Pharmaceuticals USA Inc |
| LABELER NAME: | Teva Pharmaceuticals USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 35(mg/1) |
| START MARKETING DATE: | 2015-05-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-5509_584991fa-6d03-4bd7-8094-dbf6de3e6233 |
| PRODUCT NDC: | 0093-5509 |
| APPLICATION NUMBER: | ANDA203217 |
Other RISEDRONATE SODIUM MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
